Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa.
FDA approves treatment for two rare types of non-Hodgkin lymphoma
FDA approves new drug for the treatment of adults with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy
FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
FDA approves first generic drug under Competitive Generic Therapy (CGT) designation for products with inadequate generic competition
Voluntary Recall Notice of El Guapo Jamaica Hibiscus Flower Pouches Due to Unlabeled Peanut Allergen
Mojave Foods Corporation is initiating a voluntary recall of four sizes of El Guapo Jamaica Hibiscus Flower packages in flexible packaging due to an unlabeled peanut allergen
G & C Raw, LLC Recalls Pat’s Cat Turkey, and Ground Lamb Pet Food, because of Possible Listeria Monocytogenes Health Risk
G & C Raw, of Versailles, OH is recalling 30 1-lb containers of Pat’s Cat Turkey Cat Food and 40 2-lb containers of Ground Lamb Dog Food because it has the potential to be contaminated with Listeria monocytogenes. Listeria monocytogenes can cause serious and sometimes fatal infections in animals eating the products.
G & C Raw, LLC Recalls Pat’s Cat Turkey, and Ground Lamb Pet Food, because of Possible Listeria Monocytogenes Health Risk
G & C Raw, of Versailles, OH is recalling 30 1-lb containers of Pat’s Cat Turkey Cat Food and 40 2-lb containers of Ground Lamb Dog Food because it has the potential to be contaminated with Listeria monocytogenes. Listeria monocytogenes can cause serious and sometimes fatal infections in animals eating the products.
FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder
FDA issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs to treat opioid use disorder.
FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder
FDA issued new scientific recommendations aimed at encouraging more widespread innovation and development of novel medication-assisted treatment drugs to treat opioid use disorder.
Voluntary Recall of Hostess Cookies ‘n Creme Brownies
Hostess Brands, LLC has become aware that the “Contains” statement on Hostess Cookies ‘n Creme Brownies does not list “egg” as an allergen. Although the ingredient list on the packaging identifies “egg” as an ingredient, the “Contains” statement, which is designed to further alert consumers of allergens in the products, does not include “egg”.
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps the agency is taking to support the development of novel nicotine replacement drug therapies to help smokers quit cigarettes
FDA releases the first of two draft guidances aimed at supporting the development of novel, inhaled nicotine replacement therapies that could be submitted for approval as new drugs.